ORKA Latest Press Releases

-- November 3, 2026 --

Oruka Therapeutics to Participate in Multiple Upcoming Conferences Globe Newswire 7:00 AM

-- October 26, 2026 --

Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis Globe Newswire 7:00 AM

-- October 25, 2026 --

Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026 Globe Newswire 12:00 PM

-- September 23, 2026 --

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing Globe Newswire 7:00 AM

-- September 9, 2026 --

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference Globe Newswire 4:01 PM

-- August 24, 2026 --

Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer Globe Newswire 4:01 PM

-- August 10, 2026 --

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:03 AM

Market Data Delayed 15 Minutes